Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Apimeds Pharmaceuticals US, Inc. Common Stock
No Price
06.04.2026 13:46
Current Prices from Apimeds Pharmaceuticals US, Inc. Common Stock
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
AMEX
APUS
USD
06.04.2026 13:46
1,88 USD
-
NYSE
APUS
USD
31.03.2026 15:21
1,77 USD
-
Share Float & Liquidity
Free Float18,01 %
Shares Float226.548,00
Shares Outstanding1,26 M
Company Profile for Apimeds Pharmaceuticals US, Inc. Common Stock Share
Apimeds Pharmaceuticals US, Inc. operates as a clinical stage biopharmaceutical company in the United States. It researches, develops, manufactures, commercializes, and sells Apitox, an active pharmaceutical ingredient for the treatment of inflammation and pain management symptoms associated with osteoarthritis and multiple sclerosis. The company was incorporated in 2020 and is based in Hopewell, New Jersey. Apimeds Pharmaceuticals US, Inc. is a subsidiary of Api Meds, Inc.
